ACCESSING CLASSIFIED FILES
Decrypting documents...
Your connection is being monitored
Back to Individuals
critical risk$700 million+ extracted from McKesson
John Hammergren
Former McKesson CEO
McKesson CEO, Opioid Distribution Giant
Overview
John Hammergren was CEO of McKesson, the largest pharmaceutical distributor in America, from 2001-2019. Under his leadership, McKesson distributed billions of opioid pills while ignoring suspicious orders, fueling the addiction crisis. McKesson paid $150 million in 2017 and billions more in subsequent settlements. Hammergren received over $700 million in compensation during his tenure.
Key Affiliations
Controversies & Concerns
OPIOID DISTRIBUTION: Shipped billions of pills to suspicious pharmacies
IGNORED WARNINGS: Failed to report suspicious orders
$150 MILLION FINE: DEA settlement in 2017
$7.9 BILLION: Part of Big 3 distributor settlement
$700M COMPENSATION: Enriched himself during crisis
AVOIDED PROSECUTION: No personal criminal charges
Related Investigations (2)
Criminal Charges & Violations
2 documented violations
21 U.S.C. � 823Controlled Substances Act, Distribution violations(CORPORATE SETTLEMENT)
Rome Statute Article 7(1)(k)Crimes Against Humanity, Mass death through negligence(INTERNATIONAL)
Known Associates & Connections
Steven Collis
Fellow pharmaceutical distributor CEO under DEA scrutiny
John Kapoor
Fellow pharma executive convicted in opioid-related case
Sources & Documentation
4 documented sources from official records, investigations, and reports
Personal Information
- Born
- 1959
- Birthplace
- United States
Education
- •University of Minnesota
Key Timeline
1959
Born
2001
Becomes McKesson CEO
2017
$150M DEA settlement
2019
Steps down as CEO
2022
$7.9B settlement (with Cardinal, Amerisource)